Debarment certification guidance

FDA issues draft guidance for industry on "Submitting Debarment Certification Statements" Oct. 2. The guidance clarifies specific aspects of the 1992 Generic Drug Enforcement Act with regard to the certification by companies that no debarred persons have contributed to an application for approval being submitted to the agency. Comments on the draft guidance are due by Dec. 2